David Rowan
Angel Investor
Current investment sectors
Angel investments
David Rowan has been an angel investor in the following startups:
Biofidelity
Biofidelity secures $24M in funding to revolutionize cancer care with cutting-edge genomic technology, propelling its mission to enhance and prolong the lives of cancer patients worldwide.
Optellum
Optellum secures $14 million to accelerate its AI revolution in lung cancer diagnosis, setting the stage for a patient-centered transformation in healthcare!
- 1Rebel
- Empiribox
- Pavegen
- Tokamak Energy
- ZigZag Global
Who is this angel investor?
David Rowan is an angel investor based in London, in the UK.
David Rowan, founding Editor-in-chief of WIRED’s UK edition (2008-17), has evolved into an influential figure in the tech startup scene, with investments in over 80 tech companies, such as Improbable, Grammarly, Unbabel, Maven Clinic, and Onfido. Besides directing the VOYAGERS Climate-Tech and Health-Tech Funds, he provides guidance to founders on brand storytelling. An accomplished author, his book “Non-Bullshit Innovation: Radical Ideas from the World’s Smartest Minds” hit Amazon's #1 spot in the business best-seller list. The book explores bold corporate innovation in response to technology-led disruption and is based on Rowan's travels across 20 countries. He also manages a not-for-profit project, VOYAGERS.io, dedicated to fostering close friendships and community through weekend adventures and digital networking, with communities specifically for those working in health-tech and climate-tech. During his tenure at WIRED, he developed a conference business and digital/video businesses. Prior to this, he spent 10 years as an editor at The Guardian and was trained as a journalist at The Times, also serving as a technology columnist for multiple publications.
